Molecular Templates, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MTEM research report →
About the company
Molecular Templates, Inc. (MTEM) is a clinical-stage biopharmaceutical firm dedicated to the identification and progression of biological therapies for oncology and other significant health conditions. The company's core development strategy relies on its unique engineered toxin body (ETB) drug platform to construct a robust pipeline of treatments.
- CEO
- Eric E. Poma
- IPO
- 2005
- Employees
- 62
- HQ
- Austin, TX, US
Price Chart
- Market Cap
- $658
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.61
- Div Yield
- 0.00%
- Gross Margin
- 87.94%
- Op Margin
- -18.26%
- Net Margin
- -14.18%
- ROE
- 148.79%
- ROIC
- -50.86%
- Revenue
- $57.31M · 190.10%
- Net Income
- $-8,124,000 · 91.24%
- EPS
- $-1.80 · 92.73%
- Op Income
- $-10,466,000
- FCF YoY
- 54.44%
- 52W High
- $1.59
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.26
- Beta
- 1.53
- Avg Volume
- 2.43K
Get TickerSpark's AI analysis on MTEM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 14, 24 | BIOTECH TARGET N V | sell | 1,279,820 |
| Sep 27, 24 | LALANDE KEVIN M. | other | 1,000 |
| Sep 27, 24 | Gruia Gabriela | other | 1,000 |
| Sep 27, 24 | SELICK HAROLD E | other | 1,000 |
| Sep 27, 24 | HOFFMANN DAVE | other | 1,000 |
| Sep 27, 24 | Sanders Corazon (Corsee) D. | other | 1,000 |
| Apr 2, 24 | BIOTECH TARGET N V | buy | 250,000 |
| Apr 2, 24 | BIOTECH TARGET N V | buy | 769,334 |
| Apr 2, 24 | BIOTECH TARGET N V | buy | 134,667 |
| Apr 2, 24 | LALANDE KEVIN M. | other | 1,154,154 |
Our MTEM coverage
Recent articles, reports, and earnings notes.
No research on MTEM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MTEM report →Similar companies
Peers in the same neighborhood.